Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2013; 19(46): 8696-8702
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8696
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8696
Table 1 Characteristics of 35 patients with postoperative pancreatic fistula following gastrectomy n (%)
Sex | Male | 30 (86) |
Female | 5 (14) | |
Age (yr) | mean + SD | 67.3 ± 9.5 |
BMI (kg/m2) | mean + SD | 22.1 ± 3.2 |
pT-stage | T1 | 3 (9) |
T2 | 11 (31) | |
T3 | 15 (43) | |
T4 | 6 (17) | |
pN-stage | N0 | 10 (29) |
N1 | 3 (9) | |
N2 | 9 (26) | |
N3 | 13 (36) | |
pStage | I | 6 (17) |
II | 3 (9) | |
III | 18 (51) | |
IV | 8 (23) | |
Gastrectomy | Distal | 10 (29) |
Total or others1 | 25 (71) | |
Splenectomy | Presence | 21 (60) |
Absence | 14 (40) | |
Pancreaticosplenectomy | Presence | 12 (34) |
Absence | 23 (66) | |
Lymphadenectomy | < D2 | 8 (23) |
D2 ≤ | 27 (77) | |
Resection status | R0 | 10 (29) |
R1 | 15 (42) | |
R2 | 10 (29) | |
ISGPF classification | Grade B | 17 (49) |
Grade C | 18 (51) |
Table 2 Comparison of clinicopathologic factors and International Study Group on Pancreatic Fistula classification in patients with severe postoperative pancreatic fistula between short and long duration of intensive treatments n (%)
Variables | Intensive treatment periods for POPF | 1P value | ||
< 20 d | 20 d ≤ | |||
Sex | Male | 10 (83) | 20 (87) | |
Female | 2 (17) | 3 (13) | 0.827 | |
Age (yr) | < 65 | 5 (42) | 7 (30) | |
65 ≤ | 7 (58) | 16 (70) | 0.772 | |
BMI (kg/m2) | < 21 | 5 (42) | 6 (27) | |
21 ≤ | 7 (58) | 16 (73) | 0.636 | |
pT-stage | T1 T2 | 3 (25) | 3 (13) | |
T3 T4 | 9 (75) | 20 (87) | 0.391 | |
pN-stage | N1 N2 | 5 (42) | 16 (70) | |
N3 | 7 (58) | 7 (30) | 0.217 | |
pStage | III | 4 (33) | 5 (22) | |
III IV | 8 (67) | 18 (78) | 0.736 | |
Splenectomy | Presence | 7 (58) | 14 (61) | |
Absence | 5 (42) | 9 (39) | 0.827 | |
Pancreatico-splenectomy | Presence | 2 (17) | 10 (43) | |
Absence | 10 (83) | 13 (57) | 0.149 | |
Lymphadenectomy | < D2 | 2 (17) | 6 (26) | |
D2 ≤ | 10 (83) | 17 (74) | 0.685 | |
Resection status | R0 | 5 (42) | 5 (22) | |
R1 | 4 (33) | 11 (48) | ||
R2 | 3 (25) | 7 (30) | 0.728 | |
Blood loss (g) | < 1000 | 3 (25) | 9 (39) | |
1000 ≤ | 9 (75) | 14 (61) | 0.476 | |
Operation time (min) | < 330 | 6 (50) | 11 (48) | |
330 ≤ | 6 (50) | 12 (52) | 0.815 | |
Preoperative Hb (g/dL) | < 10 | 5 (42) | 3 (13) | |
10 ≤ | 7 (58) | 20 (87) | 0.091 | |
Preoperative Alb (g/dL) | ≤ 3.5 | 3 (30) | 6 (29) | |
3.5 < | 7 (70) | 15 (71) | 1.000 | |
2Lymphocyte counts (/mm3) | < 850 | 5 (42) | 18 (78) | |
850 ≤ | 7 (58) | 5 (22) | 0.073 | |
ISGPF classification | grade B | 9 (75) | 8 (35) | |
grade C | 3 (25) | 15 (65) | 0.0353 |
Table 3 Comparison of clinical factors between grade B and C postoperative pancreatic fistula according to International Study Group on Pancreatic Fistula classification n (%)
Variables | Total | ISGPF classification | 1P value | ||
Grade B (n = 17) | Grade C (n = 18) | ||||
Sex | Male | 30 | 14 (82) | 16 (89) | |
Female | 5 | 3 (18) | 2 (11) | 0.944 | |
Age (yr) | < 65 | 12 | 9 (53) | 3 (17) | |
65 ≤ | 23 | 8 (47) | 15 (83) | 0.0353 | |
BMI (kg/m2) | < 21 | 13 | 9 (53) | 4 (24) | |
21 ≤ | 21 | 8 (47) | 13 (76) | 0.158 | |
pT-stage | T1 T2 | 6 | 4 (24) | 2 (11) | |
T3 T4 | 29 | 13 (76) | 16 (89) | 0.402 | |
pN-stage | N1 N2 | 21 | 9 (53) | 12 (67) | |
N3 | 14 | 8 (47) | 6 (33) | 0.629 | |
pStage | III | 9 | 5 (29) | 4 (22) | |
III IV | 26 | 12 (71) | 14 (78) | 0.921 | |
Splenectomy | Presence | 21 | 11 (65) | 10 (56) | |
Absence | 14 | 6 (35) | 8 (44) | 0.836 | |
Pancreaticosplenectomy | Presence | 12 | 4 (24) | 8 (44) | |
Absence | 23 | 13 (76) | 10 (56) | 0.344 | |
Lymphadenectomy | < D2 | 8 | 3 (18) | 5 (28) | |
D2 ≤ | 27 | 14 (82) | 13 (72) | 0.691 | |
Resection status | R0 | 10 | 4 (24) | 6 (33) | |
R1 | 15 | 7(41) | 8 (45) | ||
R2 | 10 | 6 (35) | 4 (22) | 0.892 | |
Blood loss (g) | < 1000 | 23 | 11 (65) | 12 (67) | |
1000 ≤ | 12 | 6 (35) | 6 (33) | 0.815 | |
Operation time (min) | < 330 | 19 | 10 (59) | 9 (50) | |
330 ≤ | 16 | 7 (41) | 9 (50) | 0.854 | |
Preoperative Hb (g/dL) | <10 | 8 | 5 (29) | 3 (17) | |
10 ≤ | 27 | 12 (71) | 15 (83) | 0.443 | |
Preoperative Alb (g/dL) | ≤ 3.5 | 9 | 4 (27) | 5 (29) | |
3.5 < | 23 | 11 (74) | 12 (71) | 0.825 | |
2Lymphocyte counts (/mm3) | < 1400 | 26 | 9 (53) | 17 (94) | |
1400 ≤ | 9 | 8 (47) | 1 (6) | 0.0073 |
Table 4 Results of multivariable logistic regression; risk factor for extremely severe postoperative pancreatic fistula
Covariate | OR | 95% Confidence limit | P value |
Lymphocyte counts (/mm3) | |||
< 1400 vs 1400 ≤ | 10.45 | 1.05-104.1 | 0.045 |
Age (yr) | |||
65 ≤vs < 65 | 3.39 | 0.602-1.886 | 0.166 |
- Citation: Komatsu S, Ichikawa D, Kashimoto K, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Risk factors to predict severe postoperative pancreatic fistula following gastrectomy for gastric cancer. World J Gastroenterol 2013; 19(46): 8696-8702
- URL: https://www.wjgnet.com/1007-9327/full/v19/i46/8696.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i46.8696